A pilot study of the impact of bacterial and fungal coinfections on mildly ill COVID-19 patients
The results demonstrate that respiratory pathogens, at least <i>M. pneumoniae</i>, can contribute to the risk of COVID-19 onset and/or severity in the vaccinated population. Meanwhile, neither bacterial agents of atypical pneumonia nor lung colonization with opportunistic pathogens are essential for recovery in patients with moderate COVID-19 infection when appropriate treatment is provided.
Authors
- M. A. Uvarova
- А. В. Иванов (ORCID: https://orcid.org/0000-0002-1676-7754)
- Anastasia N. Vaganova (ORCID: https://orcid.org/0000-0002-0101-1065)
- Diana Safarova
- Danial Djulanov
- Diana Zaitseva
Institutions
- St Petersburg University (RU)
- Ospedale regionale di Lugano (CH)
- Saint Petersburg State Pediatric Medical University (RU)
Publication Details
- Journal
- Canadian Journal of Respiratory Therapy
- Published
- 2025-08-12
- DOI
- https://doi.org/10.29390/001c.142509
- Primary Topic
- Pneumonia and Respiratory Infections
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Saint Petersburg State University